Facts and figures

Headquarters	Denmark
International	International production facilities in six countries. Affiliates or offices in 80 countries
Workforce	More than 26,000 employees (December 2007). Approximately 49% of employees are located in Denmark, 51% in the rest of the world (North America: 3,940, Japan & Oceania: 1,025, International Operations: 4,943, Europe: 3,411, Denmark 12,689). 18% within research and development 31% in production and production administration 32% in international sales and marketing 19% in administration
Product areas	Diabetes care Haemostasis management (NovoSeven®) Growth hormone therapy Hormone replacement therapy (HRT)
Sales*	41,831
Sales by business segment*	Diabetes care 30,478 Biopharmaceuticals 11,353
Turnover by region*	Europe 16,350 Japan & Oceania 4,440 North America 13,746 International Operations 7,295

* million Danish kroner, full year 2007

Novo Nordisk A/S
Bagsværd, Denmark,
CVR nr. 24 25 67 90